Form 483

Swiss Pharmaceutical Company Ltd Form 483, 2019-03-22

FDA issued a Form 483 to Swiss Pharmaceutical Company Ltd on 2019-03-22 with 2 public-safe observations.

483· Form 483 issuedHuman Drugs2 observations

Swiss Pharmaceutical Company Ltd · Tai Nan Shi, Taiwan · Issued March 22, 2019

Overview

  • 2 public-safe observations are available for this inspection.
  • 1 structured CFR citation is represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

22 Mar 2019
21 CFR 211.68(b)

Backup file not maintained

Cited by Sangeeta M Khurana

22 Mar 2019
21 CFR 211.68(b)

input/output verification

Cited by Sangeeta M Khurana

Inspected site

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.68(b)Cited across public-safe Form 483 observations2x

Full 483 report

Get the verbatim text of all 2 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere